Use of recombinant bovine alpha 1 interferon in reducing respiratory disease induced by bovine herpesvirus type 1.

Intranasal or intramuscular treatment of calves with recombinant bovine alpha 1 interferon before challenge with bovine herpesvirus type 1 and Pasteurella haemolytica reduced clinical signs, number of sick days, lung lesions, and weight loss. The effective dose was determined to be relatively broad...

Descrizione completa

Dettagli Bibliografici

Pubblicato in:	Antimicrob Agents Chemother
Autori principali:	Babiuk, L A, Lawman, M J, Gifford, G A
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	American Society for Microbiology (ASM) 1987
Soggetti:	Research Article
Accesso online:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC174827/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/3038008/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.31.5.752
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!